Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings.
Muntner P, Ghazi L, Jones J, Dhalwani N, Poudel B, Wen Y, Chen L, Wang Z, Bittner V, Kalich B, Farkouh ME, Woodward M, Colantonio LD, Rosenson RS.
Muntner P, et al. Among authors: wen y.
Adv Ther. 2024 Apr 30. doi: 10.1007/s12325-024-02868-z. Online ahead of print.
Adv Ther. 2024.
PMID: 38691317